Home LiteratureArticle Details
PMID: 8649767 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.

Oncogene ·Vol. 12 ·No. 11 ·1996-06-06 ·Pages 2279-89

Momand J, Zambetti GP

Abstract

A critical parameter affecting cell growth properties is the relative levels of the p53 tumor suppressor protein and the mdm-2 oncoprotein. Because mdm-2 overexpression is observed in several types of human cancers and its physical association with p53 appears essential for down-regulating p53 activity the proportion of p53 bound to mdm-2 was examined in four types of cells with divergent growth properties: (1) Growth arrested cells (Al) expressing high levels of wild-type p53 activity; (2) Tumorigenic cells (3T3DM) expressing high levels of mdm-2; (3) Immortalized non tumorigenic cells (Swiss3T3 and Balb/c3T3); and (4) Normal murine fibroblasts. In Al cells, greater than 78% of the p53 was not bound to mdm-2, demonstrating that excess free p53 is available for cell cycle arrest. In 3T3DM cells 100% of the p53 was bound to mdm-2 and these cells were unable to support p53-mediated transactivation, a p53 function essential for cell growth inhibition. In Swiss3T3 cells 75% of the p53 was bound to mdm-2. In Balb/c3T3 cells and normal cells no detectable mdm-2 was bound to p53. Since free p53 was detected in several of these cell lines the possibility that mdm-2 is completely titrated by p53 was investigated. However, free mdm-2 was present in all these cells. Phosphorylation of p53 does not appear to control complex formation since the free and the mdm-2-bound form of p53 from Al cells had identical phosphorylation maps. These data suggest that a high proportion of p53 bound to mdm-2 is observed in some cells with a more transformed phenotype and that p53-mdm-2 complex formation is controlled by a posttranslational event other than p53 phosphorylation.

MeSH Terms
3T3 Cells/metabolism Animals Cell Line/metabolism Electrophoresis, Polyacrylamide Gel Mice Mice, Inbred BALB C Neoplasm Proteins/metabolism Nuclear Proteins Phosphorylation Precipitin Tests Protein Processing, Post-Translational Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-mdm2 Rats Transcriptional Activation Tumor Suppressor Protein p53/metabolism
Chemicals
Neoplasm Proteins Nuclear Proteins Proto-Oncogene Proteins Tumor Suppressor Protein p53 Mdm2 protein, mouse Mdm2 protein, rat Proto-Oncogene Proteins c-mdm2
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Momand J
Department of Cell and Tumor Biology, City of Hope National Medical Center,Duarte, California 91010-0269, USA.
Zambetti G P
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
1996-06-06
Pages
2279-89
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · 5 P30CA 21765 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]